Abeona Therapeutics (ABEO) Return on Invested Capital (2025 - 2026)
Abeona Therapeutics' (ABEO) quarterly Return on Invested Capital came in at 0.03% in Q1 2026, up 12.11% quarter-over-quarter from 0.03% in Q4 2025.
Abeona Therapeutics (ABEO) Return on Invested Capital (2025 - 2026) Analysis & Trends
Abeona Therapeutics' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.03% for Q1 2026.
- On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.03% in Q1 2026; TTM through Mar 2026 was 0.03%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.08%, up 4.0% from the prior year.
- Return on Invested Capital advanced to 0.03% in Q1 2026 per ABEO's latest filing, from 0.03% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.03% in Q1 2026 and bottomed at 0.03% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03% |
| Dec 31, 2025 | -0.03% |